Publications by authors named "Angelo Palmas"

Claim this Profile
O
Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control study.
Pierluigi Cocco, Federico Meloni, Carlotta Trobbiani, Lucia Miligi, Daniela Ferrante, Angelo Palmas

Environ Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.
Rexhep Durmo, Stephane Chauvie, Carla Minoia, Fabrizio Bergesio, Federico Fallanca, Angelo Palmas

Am J Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial.
Simone Ragaini, Anna Galli, Elisa Genuardi, Martina Gandossini, Beatrice Alessandria, Angelo Palmas

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of insularity on SARS-CoV-2 diffusion: Recapitulating three years of COVID-19 pandemic in the island of Sardinia.
Nicole Grandi, Roberto Cusano, Giovanna Piras, Maura Fiamma, Maria Itria Monne, Angelo Domenico Palmas

J Infect Public Health· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.
Mattia D'Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, Angelo Belotti, Sonia Morè, Angelo D Palmas

Blood· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Roberto Mina, Pellegrino Musto, Delia Rota-Scalabrini, Laura Paris, Barbara Gamberi, Angelo Palmas

Lancet Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner Sardinia.
Paolo Malune, Giovanna Piras, Maria Monne, Maura Fiamma, Rosanna Asproni, Angelo Domenico Palmas

Front Microbiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Francesca Gay, Pellegrino Musto, Delia Rota-Scalabrini, Luca Bertamini, Angelo Belotti, Angelo Palmas

Lancet Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island.
Giovanna Piras, Nicole Grandi, Maria Monne, Rosanna Asproni, Tatiana Fancello, Angelo D Palmas

Front Microbiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Michele Cavo, Francesca Gay, Meral Beksac, Lucia Pantani, Maria Teresa Petrucci, Angelo Palmas

Lancet Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia.
Giovanni Caocci, Marianna Greco, Veronica Frau, Rosanna Asproni, Giovanna Piras, Angelo Palmas

Ann Hematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis.
Francesca Bonello, Stefano Pulini, Stelvio Ballanti, Massimo Gentile, Stefano Spada, Angelo Palmas

Cancers (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute basophilic leukemia with U2AF1 mutation.
Antonio Carruale, Giuseppina Muntone, Rodrigo Rojas, Silvana Bonfigli, Patrizia Virdis, Angelo Palmas

Blood Cells Mol Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis.
Sara Bringhen, Massimo Offidani, Salvatore Palmieri, Francesco Pisani, Rita Rizzi, Angelo Palmas

Crit Rev Oncol Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Results of Peripheral-Blood Stem-Cell Mobilization, Collection, Cryopreservation, and Engraftment After Autologous Transplantation Confirm That the Capacity-Building Approach Offers Good Chances of Success in Critical Contexts: A Kurdish-Italian Cooperative Project at the Hiwa Cancer Hospital, Sulaymaniyah.
Ignazio Majolino, Dereen Mohammed, Dastan Hassan, Francesco Ipsevich, Chra Abdullah, Angelo Palmas

J Glob Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Start-Up of the first Hematopoietic Stem Cell Transplantation Center in the Iraqi Kurdistan: a Capacity-Building Cooperative Project by the Hiwa Cancer Hospital, Sulaymaniyah, and the Italian Agency for Development Cooperation: an Innovative Approach.
Ignazio Majolino, Dosti Othman, Attilio Rovelli, Dastan Hassan, Luqman Rasool, Angelo Palmas

Mediterr J Hematol Infect Dis· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide in heavily pretreated refractory multiple myeloma: a case report.
Angelo Palmas, Giovanna Piras, Antonella Uras, Rosanna Asproni, Marco Murineddu

Future Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. A single centre study.
Donatella Baronciani, Cristina Depau, Clara Targhetta, Daniele Derudas, Fabio Culurgioni, Angelo Palmas

Hematol Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma.
Giovanna Piras, Maria Monne, Angelo D Palmas, Anna Calvisi, Rosanna Asproni

Clin Epigenetics· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of malignant lymphoma following viral hepatitis infection.
Pierluigi Cocco, Giovanna Piras, Maria Monne, Antonella Uras, Attilio Gabbas, Angelo Palmas

Int J Hematol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.
Andrés J M Ferreri, Maurilio Ponzoni, Massimo Guidoboni, Antonio Giordano Resti, Letterio S Politi, Angelo Palmas

J Natl Cancer Inst· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
Maria Monne, Giovanna Piras, Angelo Palmas, Luigi Arru, Marco Murineddu

Am J Hematol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis